Net Income (Loss) Attributable to Parent in USD of CVS HEALTH Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CVS HEALTH Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2010 to Q3 2025.
  • CVS HEALTH Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$3.98B, a 4669% decline year-over-year.
  • CVS HEALTH Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $469M, a 90.7% decline year-over-year.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2024 was $4.61B, a 44.7% decline from 2023.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2023 was $8.34B, a 93.6% increase from 2022.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2022 was $4.31B, a 46.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

CVS HEALTH Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $469M -$3.98B -$4.06B -4669% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $4.53B $1.02B -$749M -42.3% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $5.28B $1.78B +$666M +59.8% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $4.61B $1.64B -$402M -19.6% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2025
Q3 2024 $5.02B $87M -$2.17B -96.2% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $7.19B $1.77B -$131M -6.89% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $7.32B $1.11B -$1.02B -47.9% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $8.34B $2.05B -$288M -12.3% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2025
Q3 2023 $8.63B $2.26B +$5.67B 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $2.97B $1.9B -$1.13B -37.2% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $4.09B $2.14B -$218M -9.26% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $4.31B $2.33B +$937M +67.1% 01 Oct 2022 31 Dec 2022 10-K 12 Feb 2025
Q3 2022 $3.37B -$3.41B -$5B -313% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $8.38B $3.03B +$246M +8.84% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $8.13B $2.35B +$131M +5.89% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $8B $1.4B +$424M +43.6% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2024
Q3 2021 $7.58B $1.6B +$374M +30.6% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $7.2B $2.78B -$192M -6.45% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $7.4B $2.22B +$216M +10.8% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $7.18B $973M -$774M -44.3% 01 Oct 2020 31 Dec 2020 8-K 25 May 2023
Q3 2020 $7.95B $1.22B -$306M -20% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $8.26B $2.98B +$1.04B +53.7% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $7.22B $2.01B +$586M +41.2% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q4 2019 $6.63B $1.75B +$2.17B 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2020
Q3 2019 $4.47B $1.53B +$140M +10.1% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 $4.33B $1.94B +$4.5B 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 -$171M $1.42B +$423M +42.4% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 -$594M -$419M -$3.71B -113% 01 Oct 2018 31 Dec 2018 10-K 18 Feb 2020
Q3 2018 $3.11B $1.39B +$105M +8.17% 01 Jul 2018 30 Sep 2018 10-K 18 Feb 2020
Q2 2018 $3.01B -$2.56B -$3.66B -333% 01 Apr 2018 30 Jun 2018 10-K 18 Feb 2020
Q1 2018 $6.67B $998M +$46M +4.83% 01 Jan 2018 31 Mar 2018 10-K 18 Feb 2020
Q4 2017 $6.62B $3.29B +$1.58B +92.6% 01 Oct 2017 31 Dec 2017 8-K 08 Aug 2019
Q3 2017 $5.04B $1.29B -$255M -16.6% 01 Jul 2017 30 Sep 2017 8-K 08 Aug 2019
Q2 2017 $5.3B $1.1B +$174M +18.8% 01 Apr 2017 30 Jun 2017 8-K 08 Aug 2019
Q1 2017 $5.12B $952M -$194M -16.9% 01 Jan 2017 31 Mar 2017 8-K 08 Aug 2019
Q4 2016 $5.32B $1.71B +$209M +14% 01 Oct 2016 31 Dec 2016 10-K 14 Feb 2018
Q3 2016 $5.11B $1.54B +$294M +23.6% 01 Jul 2016 30 Sep 2016 10-K 14 Feb 2018
Q2 2016 $4.81B $924M -$348M -27.4% 01 Apr 2016 30 Jun 2016 10-K 14 Feb 2018
Q1 2016 $5.16B $1.15B -$75M -6.14% 01 Jan 2016 31 Mar 2016 10-K 14 Feb 2018
Q4 2015 $5.24B $1.5B 01 Oct 2015 31 Dec 2015 10-K 09 Feb 2017
Q3 2015 $1.25B 01 Jul 2015 30 Sep 2015 10-K 09 Feb 2017
Q2 2015 $1.27B 01 Apr 2015 30 Jun 2015 10-K 09 Feb 2017
Q1 2015 $1.22B 01 Jan 2015 31 Mar 2015 10-K 09 Feb 2017
Q2 2011 $3.36B $816M -$5M -0.61% 01 Apr 2011 30 Jun 2011 10-Q 04 Aug 2011
Q1 2011 $3.37B $713M -$58M -7.52% 01 Jan 2011 31 Mar 2011 10-Q 05 May 2011
Q4 2010 $3.43B $1.03B 01 Oct 2010 31 Dec 2010 10-K 18 Feb 2011
Q3 2010 $809M 01 Jul 2010 30 Sep 2010 10-K 18 Feb 2011
Q2 2010 $821M 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011
Q1 2010 $771M 01 Jan 2010 31 Mar 2010 10-Q 05 May 2011

CVS HEALTH Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.61B -$3.73B -44.7% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 $8.34B +$4.03B +93.6% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 $4.31B -$3.69B -46.1% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025
2021 $8B +$822M +11.5% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2024
2020 $7.18B +$545M +8.22% 01 Jan 2020 31 Dec 2020 8-K 25 May 2023
2019 $6.63B +$7.23B 01 Jan 2019 31 Dec 2019 10-K 09 Feb 2022
2018 -$594M -$7.22B -109% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $6.62B +$1.31B +24.5% 01 Jan 2017 31 Dec 2017 10-K 18 Feb 2020
2016 $5.32B +$80M +1.53% 01 Jan 2016 31 Dec 2016 8-K 08 Aug 2019
2015 $5.24B +$593M +12.8% 01 Jan 2015 31 Dec 2015 10-K 14 Feb 2018
2014 $4.64B 01 Jan 2014 31 Dec 2014 10-K 09 Feb 2017
2010 $3.43B 01 Jan 2010 31 Dec 2010 10-K 18 Feb 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.